Skip to main content
Top
Published in: Hepatology International 4/2015

01-10-2015 | Original Article

AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis

Authors: Rakhi Maiwall, Suman Kumar, Shivendra Singh Chandel, Guresh Kumar, Archana Rastogi, Chhagan Bihari, Manoj Kumar Sharma, Bhaskar Thakur, K. Jamwal, Suman Nayak, R. P. Mathur, S. K. Sarin

Published in: Hepatology International | Issue 4/2015

Login to get access

Abstract

Background and aims

The current definitions of acute kidney injury (AKI) including HRS have been derived from patients with decompensated cirrhosis. No studies have carefully addressed AKI in patients with acute on chronic liver failure (ACLF). We evaluated the prevalence, spectrum, natural history and mortality of AKI at admission and new-onset AKI in hospitalized patients with ACLF and compared the results with patients with acute decompensation of cirrhosis (ADC).

Patients and methods

Consecutive patients with ACLF (n = 382) and ADC (n = 451) were prospectively studied. Serial renal and liver functions were recorded and correlated with the disease course and outcome.

Results

AKI at admission and new onset AKI in the hospital were not different in patients with ACLF and ADC (p > 0.05). However, a significant difference in the spectrum of AKI was noted; functional volume-responsive AKI was more common (p < 0.05) in ADC, while patients with ACLF more frequently had the structural form of AKI (p < 0.05). Moreover, patients with ADC had significantly less AKI progression (p < 0.05) and prolonged duration (p < 0.05), a lower requirement of RRT (p < 0.05) and also less AKI resolution (p < 0.05) compared to ACLF patients. Patients with ACLF (versus ADC) had a significantly higher mortality on multivariate analysis.

Conclusions

The kidneys are differentially affected in patients with cirrhosis with or without liver failure. Patients with ACLF with AKI have more structural AKI, greater potential for reversibility despite higher progression as well as higher mortality compared to patients with ADC. Prevention and early detection of AKI should be considered in patients with ACLF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Garcia-Tsao Guadalupe, Parikh Chirag R, Viola Antonella. Acute kidney injury in cirrhotics. Hepatology 2008;48(6):2064–2077CrossRefPubMed Garcia-Tsao Guadalupe, Parikh Chirag R, Viola Antonella. Acute kidney injury in cirrhotics. Hepatology 2008;48(6):2064–2077CrossRefPubMed
2.
go back to reference Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan A, et al. Acute-on-chronic liver failure: an update on consensus recommendations of the Asian pacific association for the study of the liver (APASL). Hepatol Int 2014;8:453–471CrossRefPubMed Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan A, et al. Acute-on-chronic liver failure: an update on consensus recommendations of the Asian pacific association for the study of the liver (APASL). Hepatol Int 2014;8:453–471CrossRefPubMed
3.
go back to reference Moreau R, Jalan R, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144(7):1426–1437CrossRefPubMed Moreau R, Jalan R, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144(7):1426–1437CrossRefPubMed
4.
go back to reference Rastogi A, Maiwall R, Bihari C, Trehanpati N, Pamecha V, Sarin SK. Two-tier regenerative response in liver failure in humans. Virchows Arch 2014;464(5):565–573CrossRefPubMed Rastogi A, Maiwall R, Bihari C, Trehanpati N, Pamecha V, Sarin SK. Two-tier regenerative response in liver failure in humans. Virchows Arch 2014;464(5):565–573CrossRefPubMed
5.
go back to reference Jalan R, Yurdaydin C, Bajaj JS, Acharya SK, Arroyo V, Lin HC, et al. World gastroenterology organization working party. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology 2014;147(1):4–10CrossRefPubMed Jalan R, Yurdaydin C, Bajaj JS, Acharya SK, Arroyo V, Lin HC, et al. World gastroenterology organization working party. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology 2014;147(1):4–10CrossRefPubMed
6.
go back to reference Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian pacific association for the study of the liver (APASL). Hepatol Int 2009;3:269–282PubMedCentralCrossRefPubMed Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian pacific association for the study of the liver (APASL). Hepatol Int 2009;3:269–282PubMedCentralCrossRefPubMed
7.
go back to reference Fagundes C, Barreto R, Guevara M, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol 2013;59(3):474–481CrossRefPubMed Fagundes C, Barreto R, Guevara M, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol 2013;59(3):474–481CrossRefPubMed
8.
go back to reference Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 2013;57:753–762PubMedCentralCrossRefPubMed Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 2013;57:753–762PubMedCentralCrossRefPubMed
9.
go back to reference Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008;3(6):1615–1619PubMedCentralCrossRefPubMed Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008;3(6):1615–1619PubMedCentralCrossRefPubMed
10.
go back to reference Bajaj JS, O’Leary JG, Reddy KR, Wong F, Biggins SW, Patton H, et al. North American consortium for the study of end-stage liver disease (NACSELD). Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology 2014;60(1):250–256PubMedCentralCrossRefPubMed Bajaj JS, O’Leary JG, Reddy KR, Wong F, Biggins SW, Patton H, et al. North American consortium for the study of end-stage liver disease (NACSELD). Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology 2014;60(1):250–256PubMedCentralCrossRefPubMed
11.
go back to reference Belcher JM, Parikh CR, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol 2013;11(12):1550–1558CrossRefPubMed Belcher JM, Parikh CR, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol 2013;11(12):1550–1558CrossRefPubMed
12.
go back to reference Wan ZH, Wang JJ, You SL, Liu HL, Zhu B, Zang H, et al. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol 2013;19(48):9432–9438PubMedCentralCrossRefPubMed Wan ZH, Wang JJ, You SL, Liu HL, Zhu B, Zang H, et al. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol 2013;19(48):9432–9438PubMedCentralCrossRefPubMed
13.
go back to reference Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015. doi:10.1136/gutjnl-2014-308874 Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015. doi:10.​1136/​gutjnl-2014-308874
14.
15.
go back to reference Nayak S, Mathur RP, Ramanarayanan S, Prakash G, Sarin SK, Vashishtha C, et al. Bile pigment nephropathy and acute tubular necrosis in decompensated cirrhotics and acute on chronic liver failure. Hepatology 2014;60(4 (Suppl)):325A Nayak S, Mathur RP, Ramanarayanan S, Prakash G, Sarin SK, Vashishtha C, et al. Bile pigment nephropathy and acute tubular necrosis in decompensated cirrhotics and acute on chronic liver failure. Hepatology 2014;60(4 (Suppl)):325A
16.
go back to reference Fickert P, Krones E, Pollheimer MJ, Thueringer A, Moustafa T, Silbert D, et al. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology 2013;58(6):2056–2069CrossRefPubMed Fickert P, Krones E, Pollheimer MJ, Thueringer A, Moustafa T, Silbert D, et al. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology 2013;58(6):2056–2069CrossRefPubMed
17.
go back to reference Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol 2014;60(6):1310–1324CrossRefPubMed Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol 2014;60(6):1310–1324CrossRefPubMed
18.
go back to reference Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut 2013;62(1):131–137CrossRefPubMed Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut 2013;62(1):131–137CrossRefPubMed
19.
go back to reference Martín-Llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011;140:488–496CrossRefPubMed Martín-Llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011;140:488–496CrossRefPubMed
20.
go back to reference Warren SE, Mitas JA 2nd, Swerdlin AH. Hypernatremia in hepatic failure. JAMA 1980;243(12):1257–1260CrossRefPubMed Warren SE, Mitas JA 2nd, Swerdlin AH. Hypernatremia in hepatic failure. JAMA 1980;243(12):1257–1260CrossRefPubMed
Metadata
Title
AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis
Authors
Rakhi Maiwall
Suman Kumar
Shivendra Singh Chandel
Guresh Kumar
Archana Rastogi
Chhagan Bihari
Manoj Kumar Sharma
Bhaskar Thakur
K. Jamwal
Suman Nayak
R. P. Mathur
S. K. Sarin
Publication date
01-10-2015
Publisher
Springer India
Published in
Hepatology International / Issue 4/2015
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-015-9653-x

Other articles of this Issue 4/2015

Hepatology International 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.